Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
for Alveolar Soft Part Sarcoma
17 locations incl. Phoenix
Sponsor: Advenchen Laboratories, LLC
Sex: All·Age: 18+
Code: NCT03016819·Phase 3·Recruiting